Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Shares Issued (2017 - 2023)

Orthopediatrics (KIDS) has disclosed Shares Issued for 7 consecutive years, with $21000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Shares Issued changed 0.0% to $21000.0 in Q3 2023 year-over-year; TTM through Dec 2024 was $139.2 million, a 0.02% change, with the full-year FY2023 number at $21000.0, down 99.98% from a year prior.
  • Shares Issued was $21000.0 for Q3 2023 at Orthopediatrics, down from $139.2 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $139.2 million in Q4 2022 to a low of -$68.6 million in Q4 2020.
  • A 5-year average of $13.4 million and a median of $75000.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: plummeted 301.53% in 2019, then soared 101719.71% in 2022.
  • Orthopediatrics' Shares Issued stood at $60.0 million in 2019, then tumbled by 214.27% to -$68.6 million in 2020, then soared by 99.8% to -$137000.0 in 2021, then skyrocketed by 101719.71% to $139.2 million in 2022, then crashed by 99.98% to $21000.0 in 2023.
  • Per Business Quant, the three most recent readings for KIDS's Shares Issued are $21000.0 (Q3 2023), $139.2 million (Q4 2022), and $21000.0 (Q3 2022).